中韩高清无专码区2021曰_色翁荡熄又大又硬又粗又视频图片_波多野结衣乳巨码无在线观看_国产91福利在线播放_国产人妻人伦精品_马来西亚潜水天堂_黄色免费网站下载_免费看黄网站黄污污污热门软件_小莹客厅激情46章至50章视频

Leping Kangxin Pharmaceutical and Chemical Co., Ltd. was established in October 2008. It is located in the Fine Chemical Industrial Park of Leping City, specifically at A-13, Tashan New District of the Industrial Park, covering an area of 50 acres. The company is a shareholding chemical enterprise dedicated to the development and production of pharmaceutical intermediates, with strong capabilities in chemical production technology and sales channels.

The company's investment is divided into two phases. The first phase involved an investment of 35 million yuan, with an annual production capacity of 300 tons of pyrazole pharmaceutical intermediates. The second phase involves an investment of 50 million yuan, aiming for an annual production capacity of 1,500 tons of pyrazole and 1,000 tons of trimethylguanidine pesticide intermediates. The company currently has a comprehensive management system covering R&D, production, quality, safety, environmental protection, and financial management. It has established functional departments including the R&D Office, Quality Control and Analysis Laboratory, Production Technology Department, Safety and Environmental Protection Department, Finance Department, and General Administration Office. A complete set of effective management systems has been implemented to ensure production safety and product quality, meeting market demands. The company employs 67 staff members, including 5 R&D personnel and 9 employees with college degrees or higher. It specializes in the R&D, production, and sales of fine chemical products and is a key enterprise in the pharmaceutical intermediate industry. The current main product, pyrazole, has an annual production capacity of 300 tons, with an annual turnover of 50 million yuan. 80% of the products are exported to Europe, the United States, Japan, and other countries. The company aligns with national industrial policies and meets the development needs of China's pharmaceutical and chemical market, delivering significant economic and social benefits.